Multifocal CNS demyelination after octreotide treatment for metastatic meningioma.

The article describes the case of a female patient with metastatic somatostatin receptor-positive meningioma who was diagnosed with multifocal central nervous system (CNS) demyelination after octreotide therapy. It discusses the findings of a magnetic resonance imaging (MRI) conducted on the patient. It concluded that there is a possible risk for autoimmune medicated focal demyelination by octreotide treatment in polyallergic patients.